FdaApplication
ANDA 084617
Identifiers
- fda_app_no: ANDA084617
Properties
| Property | Value |
|---|---|
| applicant_name | SANDOZ INC |
| application_type | ANDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DRALSERP | HYDRALAZINE HYDROCHLORIDE; RESERPINE | 25MG;0.1MG | TABLET;ORAL |
1 product